GlobalData on MSN17h
Delcath to trial Hepzato drug device combo in colorectal cancerThe company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...
Elicio Therapeutics, Inc. (Nasdaq: ELTX, "Elicio Therapeutics” or "Elicio”), a clinical-stage biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback